Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Entinostat|DRUG: Placebo|DRUG: Exemestane
Sponsor: Taizhou EOC Pharma Co., Ltd.